Skip to content
Brand AI

Shouxiangu

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2018

    Reishi Spore Powder Accused of False Advertising Over Anti-Cancer Implications

    In 2018, a media investigation found that offline stores of Shouxiangu, the “first Ganoderma lucidum stock,” claimed that reishi spore powder could “fight cancer” and “assist in tumor treatment,” conflating health food with traditional Chinese medicine decoction pieces; the Wuyi County Market Supervision Administration determined that its advertising constituted misleading commercial promotion. The company admitted that frontline staff might have made promotional violations and promised rectification and training. Administrative determination, company rectification.

    Source